Command Palette

Search for a command to run...

NURECA

290.84.02 (1.4%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Net Sales increased to ₹31.74 crore in Q1 2025 from ₹26.46 crore in Q4 2024, indicating healthy growth momentum.
  • Net Profit rebounded to ₹2.47 crore in Q1 2025 from a loss of ₹2.8 crore in Q4 2024, signaling operational recovery.
  • Improved Other Income in Q1 2025 suggests better investment strategies or asset management compared to previous quarters.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendDec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25
Revenue
22.3716.9720.2731.1926.4631.7434.1837.74
Expenses
27.3322.1823.4434.4431.1931.6835.5235.46
Operating Profit
-4.96-5.21-3.17-3.25-4.730.06-1.342.28
Other Income
5.90-1.265.793.171.481.992.572.32
Interest
0.110.180.150.270.170.620.250.46
Depreciation
0.590.600.660.620.540.520.530.54
Profit Before Tax
0.94-6.472.62-0.07-3.252.051.234.60
Tax
0.78-2.330.960.41-0.45-0.420.420.97
Net Profit
0.16-4.151.66-0.48-2.802.470.813.63
EPS in Rs
0.16-4.151.66-0.48-2.802.470.813.63